BELLEVUE GROUP AG – Arcus Biosciences, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$2.18M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+3.24%
quarter
Arcus Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.33% | -6.6K shares | -99K | $26.16 | 83.5K |
| Q2 2022 | share | Decrease | -19.34% | -21.6K shares | -1.24M | $25.34 | 90.1K |
| Q1 2022 | share | Increase | +27.66% | 24.2K shares | -16K | $31.56 | 111.7K |
| Q4 2021 | share | Decrease | -7.60% | -7.2K shares | 239K | $41.95 | 87.5K |
| Q3 2021 | share | Increase | +26.27% | 19.7K shares | 1.24M | $34.87 | 94.7K |
| Q2 2021 | share | 0.00% | 0 shares | -46K | $27.46 | 75K | |
| Q1 2021 | share | Increase | +47.06% | 24K shares | 782K | $28.08 | 75K |
| Q4 2020 | share | Increase | 0.00% | 51K shares | 1.32M | $25.96 | 51K |